Intelligent Cancer Testing That Accelerates Care
Avitia transforms cancer care with its powerful and comprehensive platform technology. Now no matter where any lab or oncologist is located, they can leverage Avitia’s solutions to deliver targeted treatments faster — providing patient-centric care at reduced operational costs.
Trusted by Global Leaders
Empowering Labs Where Patients Need Care Most
Avitia’s technology ensures our partners worldwide have cost-effective molecular testing solutions with rapid turnaround time to diagnose and treat cancer patients. Instead of sending out valuable samples to third-party laboratories, Avitia enables timely and relevant cancer mutation identification from locally conducted assays. This provides oncologists with targeted treatment options and clinical trial matching, allowing patients to receive the most relevant care while growing local expertise in precision diagnostics.
Outpace Cancer with Targeted Technology
Avitia's modular platform provides comprehensive, end-to-end testing solutions to rapidly identify cancer mutations and appropriate treatments. The platform reduces inefficiencies and delays by using in-house testing, as well as multi-gene targeted panels to precisely pinpoint specific cancer abnormalities. By accelerating diagnostic turnaround time, patients can begin treatment faster, significantly improving outcomes.
Actionable Targeted Panels
Provide ready-to-use NGS-based tissue and liquid biopsy panels that perform with high accuracy, empowering healthcare providers with actionable diagnostics that integrate seamlessly into their workflows.
Precision Diagnostics Platform
Avitia uses AI/Machine Learning to deliver secure, distributed bioinformatics and diagnostic expertise. It tailors diagnostics to regional and population-specific needs while enabling collaboration on new tests and integration of third-party diagnostics.
Collaborative Reporting Solutions
The platform integrates diverse knowledge bases to identify personalized treatment options and connect to localized clinical trials, enabling precise, community-focused care. It scales expertise across networks, enhancing oncologists' time with shared insights and streamlined workflows.
Transform Cancer Care with Avitia
Timely diagnosis and treatment are key to improving cancer patients’ lives. That’s why Avitia brings advanced molecular testing directly to labs, helping healthcare teams get faster, more accurate cancer insights. Our on-site testing solutions reduce waiting times, cut diagnostic costs, and give doctors the information they need to help patients begin targeted treatments sooner.
Avitia provides labs with streamlined tools that enhance operational efficiency and reporting. This seamlessly integrates into existing systems, reducing delays by conducting tests in-house instead of sending them to centralized labs.
On-Site Testing
Enable any lab to perform advanced molecular diagnostics directly on-site instead of using external labs. These streamlined workflows bring faster results to patients by reducing testing time and lowering costs, all while establishing local precision diagnostics expertise.
Powerful Bioinformatics
Leverage AI-powered bioinformatics platform for accurate, actionable insights. Avitia equips labs with everything needed to enhance operational efficiency.
Streamlined Process
Avitia’s end-to-end solutions integrate seamlessly with Laboratory Information Management Systems (LIMS) — reducing testing delays, improving turnaround times, and lowering operational costs.
Avitia empowers clinicians to provide precise, patient-centric care by leveraging NGS technology and AI-powered analytics. By delivering actionable insights, Avitia enables real-time genomic data access and clinical insights that assist treatment decision-making.
Identify Cancer Mutations
Pinpoint actionable genomic mutations with Avitia’s AI-powered molecular diagnostics, delivering precise and patient-specific results that confidently guide treatment decisions.
Intelligent Reporting
Avitia’s platform provides clear and actionable reports, streamlining treatment decision-making processes with real-time data insights, as well as diagnostic accuracy.
Increased Treatment Access
Empower clinicians with tools that provide access to the up-to-date available treatment options and clinical trials, enhancing patient outcomes by enabling faster, more accessible care.
Creating targeted, data-driven care pathways that minimize the need for invasive treatments and prioritize patient well-being. Patients can now join the over 40,000 molecular tests Avitia’s already deployed globally to diagnose and treat cancer faster.
Test Closer to Home
Cost-effective testing near point-of-care assures patients don’t travel far for testing, guaranteeing that precision oncology access is no longer subject to geographic or economic barriers.
Begin Treatments Faster
Through access to local and affordable testing, patients can start the right treatment faster — allowing them to focus on healing.
Whole Patient Approach
Avitia’s enriched information provides recommendations specific to a patient’s demographic, creating the most appropriate treatments to improve outcomes and quality of life.
Avitia offers partnership opportunities through consortium participation, research collaborations, white paper contributions, and health data projects.
Diverse Data Collaborations
Avitia’s unique distributed partnership model provides data insights for diverse patient populations and practice settings to advance innovative cancer care solutions.
Reimbursement Expertise
Understand reimbursement complexities with Avitia to meet the growing demand for liquid biopsy and integrate other impactful solutions into the healthcare ecosystem.
Strategic Collaborations
Collaborate on transformative projects and research initiatives that tackle key clinical oncology challenges by leveraging Avitia’s unique patient understanding.
Latest from Avitia
Frequently Asked Questions
Avitia creates modular and cost-effective molecular testing oncology solutions that improve patient outcomes. We empower labs and clinicians with innovative diagnostics that reduce costs and improve access to personalized treatments.
Avitia’s end-to-end platform solution seamlessly integrates into any lab, rapidly providing advanced bioinformatics and personalized treatment planning. This empowers clinical labs and oncologists to perform on-site precision diagnostics, accelerating patient management.
Avitia’s NGS-based molecular tests are tailored for clinical and research applications. Our targeted tissue and liquid biopsy panels are robust performing — ensuring patient tumor testing results are accurate, actionable, as well as timely. Additionally, Avitia’s streamlined processes and advanced technology are built to integrate with comprehensive tests like CGP and low-pass whole genome. This provides labs and oncologists with diagnostic flexibility, as well as operational efficiency.
Avitia offers comprehensive end-to-end support, including lab setup consulting, regulatory compliance, and technical guidance. The modular systems enable partners to deliver high-quality diagnostics, and we empower local clinicians with advanced insights.
With the solution utilizing widely available materials and a modular technology system, Avitia eliminates the need for proprietary testing kits and supports equipment flexibility — reducing costs without compromising quality. This ensures accessibility to high-quality NGS testing solutions for labs of all sizes — even in underserved regions.
Avitia is transforming global oncology diagnostics by creating modular, scalable, and cost-effective solutions that allow targeted treatments for better patient outcomes. By targeting cancer with precision, Avitia puts time back on the patients’ side and reduces the need for unnecessary procedures and treatments.
Stay Ahead of Cancer Today
